DIAGNOSTIC MARKERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA

Studies of probable significance of different immunological mediators for the development of chronic allergic inflammation in patients with allergic bronchopulmonary aspergillosis (ABPA) are necessary in order to specify potential targets for therapeutic intervention and timely diagnosis of the dise...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ya. I. Kozlova, E. V. Frolova, L. V. Filippova, A. E. Uchevatkina, O. V. Aak, G. I. Solovyeva, N. N. Klimko
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2018
Materias:	aspergillus spp. a. fumigatus allergic bronchopulmonary aspergillosis asthma chemokines cytokines itraconazole Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/41ace962318c4681ad7b0d84a94962c9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:41ace962318c4681ad7b0d84a94962c9
record_format	dspace
spelling	oai:doaj.org-article:41ace962318c4681ad7b0d84a94962c92021-11-18T08:03:47ZDIAGNOSTIC MARKERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA1563-06252313-741X10.15789/1563-0625-2018-4-561-570https://doaj.org/article/41ace962318c4681ad7b0d84a94962c92018-06-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/1564https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XStudies of probable significance of different immunological mediators for the development of chronic allergic inflammation in patients with allergic bronchopulmonary aspergillosis (ABPA) are necessary in order to specify potential targets for therapeutic intervention and timely diagnosis of the disease. The purpose of present study was to determine the features of immune response regulation, and to identify diagnostic markers associated with development of ABPA in patients with bronchial asthma, and to evaluate clinical and immunological efficacy of specific antimycotic therapy.The study involved 13 patients with ABPA, 14 patients with bronchial asthma with fungal sensitization (BAFS), 17 patients with bronchial asthma (BA) and 12 apparently healthy individuals. Levels of thymic stromal lymphopoietin (TSLP), thymus and activation-regulated chemokine (TARC), IL-8, as well as levels of total IgE and specific IgE to Aspergillus fumigatus (A. fumigatus) were measured in blood serum by enzyme immunoassay; blood eosinophil counts were also made. Monitoring of these immunological markers in the course of antimycotic therapy was carried out.Significantly higher numbers of eosinophils, increased levels of total IgE and sIgE for A. fumigatus, as well as TARC and IL-8 in serum were revealed in patients with ABPA when compared to the patients with BA. No significant differences in TSLP content were found between the examined groups of patients. A positive correlation between the levels of sIgE to A. fumigatus and contents of TARC and IL-8, numbers of eosinophils, and total IgE levels confirms the important diagnostic value of proinflammatory cytokines in ABPA patients. In the course of itraconazole medication, a positive clinical and immunological dynamics in ABPA patients was revealed. After 12 weeks of therapy, a significant increase in AST, FEV1 and Tiffno respiratory indexes, along with decreased number of eosinophils, total IgE levels, and a trend towards a decrease in TARC and IL-8 levels were documented. This dynamics confirms clinical efficiency of antifungal drugs when treating chronic allergic inflammation in ABPA patients.Implementation of modern immunological biomarkers, alongside with traditional indicators, will allow to differentially evaluate a probability for ABLA development in patients with bronchial asthma, to present additional evidence for discerning early stages of the disease, and to conclude about the efficiency of the therapy applied.Ya. I. KozlovaE. V. FrolovaL. V. FilippovaA. E. UchevatkinaO. V. AakG. I. SolovyevaN. N. KlimkoSPb RAACIarticleaspergillus spp.a. fumigatusallergic bronchopulmonary aspergillosisasthmachemokinescytokinesitraconazoleImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 20, Iss 4, Pp 561-570 (2018)
institution	DOAJ
collection	DOAJ
language	RU
topic	aspergillus spp. a. fumigatus allergic bronchopulmonary aspergillosis asthma chemokines cytokines itraconazole Immunologic diseases. Allergy RC581-607
spellingShingle	aspergillus spp. a. fumigatus allergic bronchopulmonary aspergillosis asthma chemokines cytokines itraconazole Immunologic diseases. Allergy RC581-607 Ya. I. Kozlova E. V. Frolova L. V. Filippova A. E. Uchevatkina O. V. Aak G. I. Solovyeva N. N. Klimko DIAGNOSTIC MARKERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA
description	Studies of probable significance of different immunological mediators for the development of chronic allergic inflammation in patients with allergic bronchopulmonary aspergillosis (ABPA) are necessary in order to specify potential targets for therapeutic intervention and timely diagnosis of the disease. The purpose of present study was to determine the features of immune response regulation, and to identify diagnostic markers associated with development of ABPA in patients with bronchial asthma, and to evaluate clinical and immunological efficacy of specific antimycotic therapy.The study involved 13 patients with ABPA, 14 patients with bronchial asthma with fungal sensitization (BAFS), 17 patients with bronchial asthma (BA) and 12 apparently healthy individuals. Levels of thymic stromal lymphopoietin (TSLP), thymus and activation-regulated chemokine (TARC), IL-8, as well as levels of total IgE and specific IgE to Aspergillus fumigatus (A. fumigatus) were measured in blood serum by enzyme immunoassay; blood eosinophil counts were also made. Monitoring of these immunological markers in the course of antimycotic therapy was carried out.Significantly higher numbers of eosinophils, increased levels of total IgE and sIgE for A. fumigatus, as well as TARC and IL-8 in serum were revealed in patients with ABPA when compared to the patients with BA. No significant differences in TSLP content were found between the examined groups of patients. A positive correlation between the levels of sIgE to A. fumigatus and contents of TARC and IL-8, numbers of eosinophils, and total IgE levels confirms the important diagnostic value of proinflammatory cytokines in ABPA patients. In the course of itraconazole medication, a positive clinical and immunological dynamics in ABPA patients was revealed. After 12 weeks of therapy, a significant increase in AST, FEV1 and Tiffno respiratory indexes, along with decreased number of eosinophils, total IgE levels, and a trend towards a decrease in TARC and IL-8 levels were documented. This dynamics confirms clinical efficiency of antifungal drugs when treating chronic allergic inflammation in ABPA patients.Implementation of modern immunological biomarkers, alongside with traditional indicators, will allow to differentially evaluate a probability for ABLA development in patients with bronchial asthma, to present additional evidence for discerning early stages of the disease, and to conclude about the efficiency of the therapy applied.
format	article
author	Ya. I. Kozlova E. V. Frolova L. V. Filippova A. E. Uchevatkina O. V. Aak G. I. Solovyeva N. N. Klimko
author_facet	Ya. I. Kozlova E. V. Frolova L. V. Filippova A. E. Uchevatkina O. V. Aak G. I. Solovyeva N. N. Klimko
author_sort	Ya. I. Kozlova
title	DIAGNOSTIC MARKERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA
title_short	DIAGNOSTIC MARKERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA
title_full	DIAGNOSTIC MARKERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA
title_fullStr	DIAGNOSTIC MARKERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA
title_full_unstemmed	DIAGNOSTIC MARKERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA
title_sort	diagnostic markers of allergic bronchopulmonary aspergillosis in patients with bronchial asthma
publisher	SPb RAACI
publishDate	2018
url	https://doaj.org/article/41ace962318c4681ad7b0d84a94962c9
work_keys_str_mv	AT yaikozlova diagnosticmarkersofallergicbronchopulmonaryaspergillosisinpatientswithbronchialasthma AT evfrolova diagnosticmarkersofallergicbronchopulmonaryaspergillosisinpatientswithbronchialasthma AT lvfilippova diagnosticmarkersofallergicbronchopulmonaryaspergillosisinpatientswithbronchialasthma AT aeuchevatkina diagnosticmarkersofallergicbronchopulmonaryaspergillosisinpatientswithbronchialasthma AT ovaak diagnosticmarkersofallergicbronchopulmonaryaspergillosisinpatientswithbronchialasthma AT gisolovyeva diagnosticmarkersofallergicbronchopulmonaryaspergillosisinpatientswithbronchialasthma AT nnklimko diagnosticmarkersofallergicbronchopulmonaryaspergillosisinpatientswithbronchialasthma
_version_	1718422344140062720

DIAGNOSTIC MARKERS OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN PATIENTS WITH BRONCHIAL ASTHMA

Ejemplares similares